Sebastian Meltzer
Overview
Explore the profile of Sebastian Meltzer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
OBrien R, Meltzer S, Buckley C, Heeran A, Nugent T, Donlon N, et al.
Cancer Lett
. 2024 Sep;
604:217253.
PMID: 39278399
Resistance to neoadjuvant chemoradiation therapy (neo-CRT) is a significant clinical problem in the treatment of locally advanced rectal cancer. Identification of novel therapeutic targets and biomarkers predicting therapeutic response is...
2.
Ree A, Hoye E, Esbensen Y, Beitnes A, Negard A, Bernklev L, et al.
Oncoimmunology
. 2024 Jul;
13(1):2372886.
PMID: 38952672
The randomized METIMMOX trial (NCT03388190) examined if patients with previously untreated, unresectable abdominal metastases from microsatellite-stable (MSS) colorectal cancer (CRC) might benefit from potentially immunogenic, short-course oxaliplatin-based chemotherapy alternating with...
3.
Cabrero-de Las Heras S, Hernandez-Yague X, Gonzalez A, Losa F, Soler G, Buges C, et al.
Biomed Pharmacother
. 2024 Jun;
176:116857.
PMID: 38850664
Metastatic colorectal cancer (mCRC) currently lacks reliable biomarkers for precision medicine, particularly for chemotherapy-based treatments. This study examines the behavior of 11 CXC chemokines in the blood of 104 mCRC...
4.
Puco K, Fagereng G, Brabrand S, Niehusmann P, Store Blix E, Samdal Steinskog E, et al.
Acta Oncol
. 2024 May;
63:379-384.
PMID: 38779911
Background And Purpose: In Norway, comprehensive molecular tumour profiling is implemented as part of the public healthcare system. A substantial number of tumours harbour potentially targetable molecular alterations. Therapy outcomes...
5.
Ree A, Saltyte Benth J, Hamre H, Kersten C, Hofsli E, Guren M, et al.
Br J Cancer
. 2024 Apr;
130(12):1921-1928.
PMID: 38664577
Background: We evaluated first-line treatment of metastatic microsatellite-stable colorectal cancer with short-course oxaliplatin-based chemotherapy alternating with immune checkpoint blockade. Methods: Patients were randomly assigned to chemotherapy (the FLOX regimen; control...
6.
Helland A, Samdal Steinskog E, Store Blix E, Flobak A, Brabrand S, Puco K, et al.
Tidsskr Nor Laegeforen
. 2024 Jan;
144(1).
PMID: 38258713
No abstract available.
7.
Knuth F, Tohidinezhad F, Winter R, Bakke K, Negard A, Holmedal S, et al.
Sci Rep
. 2024 Jan;
14(1):258.
PMID: 38167665
Radiomics objectively quantifies image information through numerical metrics known as features. In this study, we investigated the stability of magnetic resonance imaging (MRI)-based radiomics features in rectal cancer using both...
8.
Bjornetro T, Bousquet P, Redalen K, Troseid A, Luders T, Stang E, et al.
BMC Cancer
. 2023 Jul;
23(1):650.
PMID: 37438741
Background: Recent reports have demonstrated that the entire mitochondrial genome can be secreted in extracellular vesicles (EVs), but the biological attributes of this cell-free mitochondrial DNA (mtDNA) remain insufficiently understood....
9.
Buckley C, Yin X, Meltzer S, Ree A, Redalen K, Brennan L, et al.
Int J Mol Sci
. 2023 Apr;
24(8).
PMID: 37108244
Resistance to neoadjuvant chemoradiation therapy is a significant clinical challenge in the management of rectal cancer. There is an unmet need to identify the underlying mechanisms of treatment resistance to...
10.
Bakke K, Meltzer S, Grovik E, Negard A, Holmedal S, Mikalsen L, et al.
Phys Imaging Radiat Oncol
. 2023 Jan;
25:100417.
PMID: 36718357
Background And Purpose: Measuring rectal tumour response to radiation is pivotal to restaging patients and for possibly stratification to a watch-and-wait strategy. Recognizing the importance of the tumour microenvironment, we...